Image not available in RecallScope.
Nitto Pharmaceutical Industries “New Calcichew D3” - Recall
Official notice
7 Jul 2026
Last checked
27 Oct 2026
An official CAA Japan notice concerns Nitto Pharmaceutical Industries “New Calcichew D3” - Recall. It was confirmed that the content of the active ingredient cholecalciferol (vitamin D3) may fall below the approved specification within the shelf life. Reason for recall: Stability monitoring conducted by our company confirmed that, in some manufacturing lots, the content of the active ingredient cholecalciferol (vitamin D3) may fall below the approved specification within the shelf life. We have therefore decided to voluntarily recall products bearing the affected manufacturing numbers. Specific potential health effects: Although the content of the active ingredient cholecalciferol (vitamin D3) may fall below the approved specification, we believe there is no risk of an impact on safety or serious adverse health effects arising from this issue. No adverse health effects thought to be attributable to this issue have been reported to date. Published 2026-07-07.
What to do now
We have identified all shipment destinations for the affected product lots and will notify them of the recall in writing and promptly collect the products. Anyone who has a recalled product should call the “Contact desk for inquiries about recalls, refunds, and returns” below to complete the necessary procedure.
Recall number
2-12876
Official notice
2026-07-07
The hazard
The hazard
It was confirmed that the content of the active ingredient cholecalciferol (vitamin D3) may fall below the approved specification within the shelf life. Reason for recall: Stability monitoring conducted by our company confirmed that, in some manufacturing lots, the content of the active ingredient cholecalciferol (vitamin D3) may fall below the approved specification within the shelf life. We have therefore decided to voluntarily recall products bearing the affected manufacturing numbers. Specific potential health effects: Although the content of the active ingredient cholecalciferol (vitamin D3) may fall below the approved specification, we believe there is no risk of an impact on safety or serious adverse health effects arising from this issue. No adverse health effects thought to be attributable to this issue have been reported to date.
How to check if you're affected
How to check if you're affected
Compare the product name and identifiers below with the item you own. Check the official notice for the affected products and next steps.
Recall Numbers
Checked manually this time?
Follow brands and keywords in the app to receive alerts for matching official notices.
Turn on recall alertsAffected products
Affected products
Product 1
Hazard
Where it was sold
Where it was sold
Retailer information is not currently available in RecallScope. Check the official notice for distribution details.
Location 1
Affected area 1
Company & contacts
Company & contacts
Brand
Manufacturer
Phone
Brand: 日東薬品工業. Contact: お客様からの回収・返金・返品に関するお問い合わせ窓口. Phone 0120-567-087, 075-921-7048.
Source & status
Source & status
Recall details
Recall details
Recall number
Event id
Source tier
Documents, notices & source
See the official notice and source documents for full details.
View full official noticeWeekly recall digest
Get next week's recalls before you need them.
One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.
The digest arrives once a week. For matching recall alerts after notices are processed, get the app.
This recall was published 7 Jul 2026. The next one won't wait for you to search.
RecallScope checks listed publishers for the brands and VINs you follow, and can alert you when a matching notice is processed.
